Skip to main navigation Skip to search Skip to main content

Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI

  • Tae Hyun Yang
  • , Han Young Jin
  • , Kyu Nam Choi
  • , Ungjeong Do
  • , Hyung Jun Kim
  • , Sang Ryul Chung
  • , Jeong Sook Seo
  • , Jae Sik Jang
  • , Dae Kyeong Kim
  • , Dong Soo Kim
  • Inje University

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science